Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On February 9, 2023, the Centers for Medicare and Medicaid Services (CMS) issued initial program guidance related to the implementation of the Prescription Drug Inflation Rebate...
Imagine the federal government created a program intended to help poor and uninsured patients in underserved communities better afford the healthcare services they need. Then, imagine that same federal safety net program accomplished the very opposite, lining the pockets of healthcare providers rather than helping vulnerable people struggling to afford the medicines they rely on to treat and manage their conditions — all while Washington policymakers ignored their oversight duties.
Centers for Medicare and Medicaid Services CMS released two highly-anticipated guidance documents detailing the agency’s proposed implementation of the Medicare Part B and Medicare Part D Prescription Drug Inflation Rebate Programs.
On February 9, 2023, the Centers for Medicare and Medicaid Services (“CMS”) released two highly-anticipated guidance documents (the “Guidance”) detailing the agency’s proposed...
On February 7, 2023, the U.S. Department of Health and Human Services Office of Inspector General (OIG) published a report entitled, "Technical Assistance Brief...